This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Viracta Therapeutics Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: David Slack: Innovator in Cancer Treatment
Introduction
David Slack is a notable inventor based in Cardiff, California. He has made significant contributions to the field of cancer treatment, particularly in the area of virally associated cancers. His innovative approach focuses on utilizing histone deacetylase inhibitors to improve patient outcomes.
Latest Patents
David Slack holds a patent titled "Methods of treating virally associated cancers with histone deacetylase inhibitors." This patent describes specific dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Additionally, the patent suggests that these schedules may include treatment with an antiviral agent, enhancing the overall effectiveness of the therapy. He has 1 patent to his name.
Career Highlights
Throughout his career, David has been dedicated to advancing cancer treatment methodologies. His work has been instrumental in developing new therapeutic strategies that aim to improve the quality of life for patients suffering from virally associated cancers.
Collaborations
David Slack has collaborated with esteemed colleagues, including Xiaohu Deng and Gail L. Brown, to further his research and development efforts in the field of oncology.
Conclusion
David Slack's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in therapeutic strategies for virally associated cancers.